Federal award (DEFINITIVE CONTRACT, fiscal year 2022)
Recipient: BOLDER BIOTECHNOLOGY INC
Awarding agency: Department of Health and Human Services / National Institutes of Health
Funding agency: Department of Health and Human Services / National Institutes of Health
Period of performance: 2023-07-01 to 2024-06-30
Current total value of award: $1650819
Description: ADVANCED DEVELOPMENT OF BBT-059 AS A RADIATION MEDICAL COUNTERMEASURE FOR DOSING UP TO 48H POST EXPOSURE"